Stanford Graduate School of Business (USA)
- Teaching Note
Novartis’ Gilenya: Navigating the Interplay Between Drug Innovation, Pricing, and Reimbursement in Different Countries’ Health Care Systems - Teaching Note
Collection: Stanford Graduate School of Business (USA)Ref.: SGSB-E489TN-EPublished: Jan 6, 2014Format: pdfPages: 24Language: English - Case
Novartis’ Gilenya: Navigating the Interplay Between Drug Innovation, Pricing, and Reimbursement in Different Countries’ Health Care Systems
Collection: Stanford Graduate School of Business (USA)Ref.: SGSB-E489-EPublished: Jan 6, 2014Format: pdfPages: 24Language: English - Case
Verily Life Sciences and Machine Learning
Collection: Stanford Graduate School of Business (USA)Ref.: SGSB-SM335-EPublished: Jul 28, 2020Format: pdfPages: 22Language: English